With Another Warning, FDA Pledges Report On CBD Use In Non-drug Products

 
• By Malcolm Spicer
Curaleaf Patch
FDA found CBD-contaning transdermal patches and other products offered by Curaleaf with disease claims and with other violations of agency regulations.

More from Regulation

More from Policy & Regulation